The Ministry of Health added almost 200 more medicines to the schedule from which pharmacist prescribers can prescribe, taking the total to 1713. A media release from the ministry says New Zealand has 37 pharmacist prescribers, largely based in collaborative, multidisciplinary health teams
Consultant cardiologist Chris Ellis discusses a patient who has steadfastly declined any offer of drug management for his hypertension and dyslipidaemia. A heart attack and some gentle explanations change his view
Dulaglutide has been funded for patients with type 2 diabetes since 1 September under Special Authority criteria. This case study summarises its potential benefits and risks, and how these should be considered when tailoring treatment to the individual
Pharmac has purchased another new medicine, baricitinib, to treat moderate to severe cases of COVID-19, with 500 courses expected in New Zealand within a matter of week
The risks posed by New Zealand’s expanding COVID-19 epidemic meant Pharmac needed to move faster than its normal processes permit in deciding to fund a new medicine for the disease, says the agency’s new chief medical officer.
Glucocorticoids are used legitimately for numerous health conditions, but there are also concerns about health risks and performance enhancement under certain circumstances. Sports physician Steve Targett runs through forthcoming regulatory changes
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management